- Home
- HWBK vs TLSA Comparison
HWBK vs TLSA Comparison
Compare HWBK & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWBK
- TLSA
- Stock Information
- Founded
- HWBK 1865
- TLSA 2013
- Country
- HWBK United States
- TLSA United Kingdom
- Employees
- HWBK N/A
- TLSA N/A
- Industry
- HWBK Major Banks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- HWBK Finance
- TLSA Health Care
- Exchange
- HWBK Nasdaq
- TLSA Nasdaq
- Market Cap
- HWBK 199.0M
- TLSA 187.0M
- IPO Year
- HWBK N/A
- TLSA 2000
- Fundamental
- Price
- HWBK $28.62
- TLSA $2.29
- Analyst Decision
- HWBK
- TLSA
- Analyst Count
- HWBK 0
- TLSA 0
- Target Price
- HWBK N/A
- TLSA N/A
- AVG Volume (30 Days)
- HWBK 10.6K
- TLSA 400.5K
- Earning Date
- HWBK 07-30-2025
- TLSA 08-12-2025
- Dividend Yield
- HWBK 2.79%
- TLSA N/A
- EPS Growth
- HWBK 397.62
- TLSA N/A
- EPS
- HWBK 2.97
- TLSA N/A
- Revenue
- HWBK $75,021,000.00
- TLSA N/A
- Revenue This Year
- HWBK N/A
- TLSA N/A
- Revenue Next Year
- HWBK N/A
- TLSA N/A
- P/E Ratio
- HWBK $9.59
- TLSA N/A
- Revenue Growth
- HWBK 33.44
- TLSA N/A
- 52 Week Low
- HWBK $20.00
- TLSA $0.63
- 52 Week High
- HWBK $35.95
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- HWBK 47.38
- TLSA 68.33
- Support Level
- HWBK $28.10
- TLSA $2.04
- Resistance Level
- HWBK $29.53
- TLSA $2.60
- Average True Range (ATR)
- HWBK 0.62
- TLSA 0.21
- MACD
- HWBK -0.07
- TLSA 0.07
- Stochastic Oscillator
- HWBK 29.05
- TLSA 73.28
About HWBK Hawthorn Bancshares Inc.
Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.